Enhanced expression of TIGIT but not neuropilin-1 in patients with type 2 diabetes mellitus.

CONCLUSIONS: The expression of TIGIT was enhanced in T2DM and the TIGIT axis could be considered as a new therapeutic purpose for the T2DM. PMID: 32540486 [PubMed - as supplied by publisher]
Source: Immunology Letters - Category: Allergy & Immunology Authors: Tags: Immunol Lett Source Type: research